Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$1.22 - $1.65 $162,188 - $219,352
-132,941 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$1.18 - $2.62 $29,389 - $65,253
-24,906 Reduced 15.78%
132,941 $205,000
Q4 2020

Feb 16, 2021

SELL
$1.05 - $2.24 $11,601 - $24,749
-11,049 Reduced 6.54%
157,847 $166,000
Q3 2020

Nov 16, 2020

BUY
$1.7 - $6.41 $287,123 - $1.08 Million
168,896 New
168,896 $343,000

About iBio, Inc.


  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $23.8M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.